77549-94-1

Basic information

• Product Name: ethyl (41R,13aS)-13a-ethyl-2,3,41,5,6,13a-hexahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylate
• Synonyms: ethyl (41R,13aS)-13a-ethyl-2,3,41,5,6,13a-hexahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylate;Vincamine Impurity 2;Vinpocetine Impurity 1;(41R,13aS)-ethyl 13a-ethyl-2,3,41,5,6,13a-hexahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylate;3β-apovincaminic acid ethyl ester;Vinpocetine Impurity G
• CAS NO: 77549-94-1
• Molecular Formula: C₂₂H₂₆N₂O₂
• Molecular Weight: 350.45
• Mol File: 77549-94-1.mol

Chemical Properties

• Melting Point: 132-134 °C
• Boiling Point: 419.5±45.0 °C(Predicted)
• Appearance: /
• Density: 1.28±0.1 g/cm3(Predicted)
• PKA: 7.87±0.60(Predicted)
• CAS DataBase Reference: ethyl (41R,13aS)-13a-ethyl-2,3,41,5,6,13a-hexahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylate(CAS DataBase Reference)
• NIST Chemistry Reference: ethyl (41R,13aS)-13a-ethyl-2,3,41,5,6,13a-hexahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylate(77549-94-1)
• EPA Substance Registry System: ethyl (41R,13aS)-13a-ethyl-2,3,41,5,6,13a-hexahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylate(77549-94-1)

Safety Data

• Hazardous Substances Data: 77549-94-1(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
Ethyl (41R,13aS)-13a-ethyl-2,3,41,5,6,13a-hexahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylate is used as a pharmaceutical agent for its potential therapeutic effects. Its unique molecular structure allows it to interact with specific biological targets, making it a promising candidate for the development of new drugs to treat various diseases.
Used in Research and Development:
ethyl (41R,13aS)-13a-ethyl-2,3,41,5,6,13a-hexahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylate is also used in research and development settings to study its chemical properties, potential applications, and interactions with biological systems. Its complex structure provides a basis for understanding the relationship between molecular structure and biological activity, which can inform the design of new drugs and therapeutic agents.

Upstream product

• 105221-74-7 ethyl (1S,12bR)-1-ethyl-1,2,3,4,6,7,12,12b-octahydroindolo[2,3-a]quinolizine-1-(2'-hydroxyimino)propionate 
• 23944-43-6 (1S,trans)-1-ethyl-1,2,3,4,6,7,12,12b-octahydroindolo<2,3-a>quinolizine-1-propanoic acid methyl ester 
• 85647-42-3 3-((1S,12bR)-1-Ethyl-1,2,3,4,6,7,12,12b-octahydro-indolo[2,3-a]quinolizin-1-yl)-2-[(E)-hydroxyimino]-propionic acid methyl ester 
• 141-52-6 sodium ethanolate 
• 56942-60-0 eburnamenine-14-carboxylic acid methyl ester 
• 43184-10-7 1α-ethyl-1-(2-hydroxy-2-ethoxycarbonylethyl)-1,2,3,4,6,7,12,12β-octahydroindolo-<2,3-a>quinolizine 
• 74904-38-4 (11aS,11bS)-11a-Ethyl-11-oxo-2,3,4,5,10,11,11a,11b-octahydro-1H-3a,9b-diaza-benzo[cd]fluoranthene-10-carboxylic acid ethyl ester 
• 74904-40-8 (10R,11R,11aS,11bS)-11a-Ethyl-11-hydroxy-2,3,4,5,10,11,11a,11b-octahydro-1H-3a,9b-diaza-benzo[cd]fluoranthene-10-carboxylic acid ethyl ester 
• 74904-40-8 (10S,11S,11aS,11bS)-11a-Ethyl-11-hydroxy-2,3,4,5,10,11,11a,11b-octahydro-1H-3a,9b-diaza-benzo[cd]fluoranthene-10-carboxylic acid ethyl ester 
• 40163-56-2 (+/-)-3-epivincaminic acid ethyl ester 
• 51049-26-4 (1R,12bR)-1-Ethyl-1,2,3,4,6,7,12,12b-octahydro-indolo[2,3-a]quinolizine-1-carbaldehyde 
• 64361-56-4 1α-ethyl-1β-(hydroxymethyl)-1,2,3,4,6,7,12,12bβ-octahydroindolo<2,3-a>quinolizine 
• 51049-28-6 14,15-dihydro-21-nor-1,14-secoeburnamenin-20-al 
• 74904-38-4 (11aS,11bR)-11a-Ethyl-11-oxo-2,3,4,5,10,11,11a,11b-octahydro-1H-3a,9b-diaza-benzo[cd]fluoranthene-10-carboxylic acid ethyl ester 

Downstream Products

• 57327-92-1 14-Ethoxycarbonyl-14,15-dihydro-3β,16α-eburnamenin 
• 23173-26-4 ((4¹S,13aS)-13a-ethyl-2,3,4¹,5,6,13a-hexahydro-1H-indolyl[3,2,1-de]pyridyl[3,2,1-ij][1,5]naphthyridine-12-yl)methanol 

Relevant articles and documents

Synthesis and evaluation of 2′-hydroxyethyl trans-apovincaminate derivatives as antioxidant and cognitive enhancer agents

A series of trans-2′-hydroxyethyl and 2′-acyloxyethyl apovincaminates 4b-f and 7b-f has been synthesized and evaluated for their antioxidant and antiamnesic effects. The new esters were prepared from 4a and 7a ethyl esters or from the corresponding carbox

Synthesis of pentacyclic ring systems, indolo[2,3-a][1,2]-oxazino[5,6-i]quinolizine and indolo[2,3-a]pyrano[3,2-i]-quinolizine, and their application for the synthesis of eburnamine-vincamine alkaloids

15a-Ethyl-14-carboxylic esters of the title pentacycles (6) and (8) were prepared via Wenkert's enamine (4). Both compounds can be readily transformed into indoloquinolizinylpyruvate oxime esters (5), key intermediates for the synthesis of vincamine alkal

Syntheses and Cardiovascular Activity of Stereoisomers and Derivatives of Eburnane Alkaloids

The synthesis of all the possible isomers of the eburnamenine-vincamine type alkaloids 1b, 2a*, 3a and derivatives 4, 8, 9, 10 is described.Structures were determined by 1H- and 13C-NMR spectroscopy including special techniques such as DR, DEPT, DNOE, and 2D-HSC.In contrast to the known cerebrovascular effects of cis-(3S,16S) compounds, trans-(3S,16R) derivatives show a significant peripheral vasodilator effect. Key Word: Eburnanes / Alkaloids / Cardiovascular effects / Indoloquinolizines

A NEW APPROACH TO (+/-)-APOVINCAMINE

A new approach to (+/-)-apovincamine, 2, is reported which bypasses the formation of (+/-)-vincamine, 1, and includes the dehydration of the β-hydroxy ester 7, obtained by regio-controlled alkylation of the stereochemically suitable aldehyde 6 with methyl chloroacetate.Using ethyl chloroacetate, the clinically useful apovincamine analogue, (+/-)-Cavinton, 3, is obtained. (+/-)-Apovincamine is then converted to (+/-)-vincamine, 1, by base-catalyzed oxygenation of the mixture of (+/-)-dihydroapovincamines 8 and 9.

Synthesis of Some Isotype Analogs of Vincamine, Eburnamonine and Eburnamine, and an Alternative Approach to Ethyl Apovincaminate

New synthetic analogs of Vinca minor alkaloids were described, together with a new total synthesis of ethyl apovincaminate.